Proteomic Analysis of Postoperative Delirium from a randomized trial in Older Patients undergoing Cardiac Surgery exposed to Intraoperative Normoxia versus Hyperoxia: A Nested Case-Control Study
Proteomic Analysis of Postoperative Delirium from a randomized trial in Older Patients undergoing Cardiac Surgery exposed to Intraoperative Normoxia versus Hyperoxia: A Nested Case-Control Study
批准号:
9751173
负责人:
Shahzad Shaefi
金额:
$13.13万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-08-01 至 2021-04-30
关键词:
AcuteAdultAffectAge-YearsAgingBiologicalBiological MarkersBloodBlood specimenCardiacCardiac Surgery proceduresCardiopulmonary BypassCognitiveConfusionCoronary Artery BypassCountryDataDeliriumDependenceDevelopmentDiagnosisDiseaseElderlyExposure toFunctional disorderHospitalsHumanHyperoxiaImpaired cognitionIncidenceInflammationInflammatoryInflammatory ResponseLengthLength of StayLinkMeasuresModelingMorbidity - disease rateNested Case-Control StudyNeurocognitionOperative Surgical ProceduresOrganOutcomeOxygenPathway interactionsPatientsPerioperativePhasePlasmaPopulationPostoperative PeriodPrevention approachPrevention strategyProteinsProteomicsPublic HealthRandomizedRandomized Controlled TrialsReperfusion InjuryRoleSamplingSerumSyndromeTimeVentilatorbiomarker discoverycase controlcohortcontrol trialcostcytokinedesignexperiencehuman old age (65+)improvedmortalitynovelolder patientoxidative damagepostoperative deliriumpreventprospectiveprotein biomarkerspublic health relevancerandomized trialresponsetreatment strategy
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
Delirium following cardiac surgery affects approximately 30-50% of patients, totaling 200,000
patients per year in this country alone, with patients over 70 years of age representing roughly
50% of those undergoing cardiac surgery. Perioperative delirium in the elderly cardiac surgical
patient confers a significant morbid burden of poor functional and cognitive outcome, increased
hospital length of stay and increased mortality. The public health impact of delirium in this
population will likely only increase over time, making the development of effective approaches to
prevention and treatment even more imperative. Further, there are accumulating data that
oxidative damage and inflammatory response during cardiopulmonary bypass (CPB) contributes
to postoperative organ dysfunction. Additionally, end organ dysfunction, morbidity and mortality
have been linked to the deleterious effects of hyperoxia following ischemia-reperfusion injuries
in several other disease states. In the current proposal we aim to leverage stored plasma
samples collected as part of a prospective randomized controlled trial of patients randomized to
one of two intraoperative ventilator management strategies in which the fraction of inspired
oxygen is titrated to hyperoxia (100%) or normoxia (35%) conditions with corresponding blood
oxygen levels, in order to undertake a nested, case control study. In this factorial design we will
establish four matched cohorts of delirium positive, delirium negative, hyperoxia exposed and
normoxia exposed patient samples and will apply state-of-the-art approaches, including
advanced proteomics, to assess circulating proteins with a view towards biomarker discovery.
Specifically, we aim to quantitatively assess the relationship between plasma inflammatory
biomarker load with delirium and intraoperative hyperoxia, using advanced proteomic analysis,
sampled at two intraoperative time points before and after CPB among patients 65 years old
and over undergoing CABG surgery. Using this model we will seek to further elucidate the
pathophysiological model related to delirium and hyperoxia, with the hope of identifying novel
serum biomarkers that may be predictive of, interact with, or define delirium signatures. Results
of the proposed analyses will provide the basis for further mechanistic studies to inform the
development of prevention and treatment strategies for postoperative delirium in cardiac surgery
and used to lessen the harmful impact of delirium in aging adults.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Sepsis and the benefits of permissive hypoxia
-
批准号:9806556
-
项目类别:
-
资助金额:$19.39万
-
财政年份:2019
-
负责人:Shahzad Shaefi
-
依托单位:
Sepsis and the benefits of permissive hypoxia
-
批准号:10450186
-
项目类别:
-
资助金额:$19.39万
-
财政年份:2019
-
负责人:Shahzad Shaefi
-
依托单位:
Sepsis and the benefits of permissive hypoxia
-
批准号:9982349
-
项目类别:
-
资助金额:$19.39万
-
财政年份:2019
-
负责人:Shahzad Shaefi
-
依托单位:
Sepsis and the benefits of permissive hypoxia
-
批准号:10224259
-
项目类别:
-
资助金额:$19.39万
-
财政年份:2019
-
负责人:Shahzad Shaefi
-
依托单位:
海外基金